Saxenda (liraglutide)

pCPA File Number: 21602
Negotiation Status:
Negotiations were not pursued
Indication(s):
Chronic weight management
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
SR0668-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: